Assessing Cheese Whey Components for Their Potential to Improve Intestinal Health (P06-097-19)
Academic Article
Overview
Additional Document Info
View All
Overview
abstract
Abstract
Objectives
To evaluate the potential of cheese whey bioactive components for intestinal health and barrier function in vitro.
Methods
HT29-MTX intestinal globet cells were treated with whey protein isolate (WPI), glycomacropeptides (GMP) and a galacto-oligosacharide rich whey protein isolate (WPI-GOS) followed by challenge with lipopolysaccharides (LPS, 4 g/ml). Reactive oxygen species (ROS) production was assessed using the 2,7 dichlorofluorescein diacetate (DCFH-DA) assay. Gene and protein expression of intestinal inflammation biomarkers were also assessed using standard analytical techniques. The effects of WPI, WPI-GOS and GMP on barrier function were assessed on a co-culture (Caco-2/HT29-MTX in a 75/25 ratio, respectively) cell model through the transepithelial electrical resistance (TEER) and apparent permeability (Papp) assays; whereas protein expression of tight junction biomarkers was assessed by Western Blots.
Results
WPI, GMP and WPI-GOS did not inhibit cell viability of colon cells within a dose range of 25100 g/ml. LPS induced ROS production in HT29-MTX cells up to 1.92 -fold of control and this effect was prevented by WPI, GMP and WPI-GOS (100 g/ml) that maintained ROS down to levels that were similar to controls not challenged with LPS. GMP protected colon cells at a highest extent against the expression of inflammatory biomarkers (nuclear factor kappa (NF-k), tumor necrosis factor (TNF-) and toll-like receptor 4 (TLR-4)) on HT29-MTX cells challenged with LPS and maintained NF-k and TNF- at levels similar to untreated control. In addition, GMP improved TEER (1.3-fold of untreated control) and decreased intestinal permeability by 64% in Caco-2/HT29-MTX co-cultures. Finally, these results were accompanied by the upregulation of tight junction proteins (Claudin-1, Claudin-3, Occludin and Zonulin-1) exerted by GMP and WPI at similar levels.
Conclusions
WPI, GMP and WPI-GOS protected against ROS production at similar levels. However, GMP protected colon cells against LPS-induced inflammation and improved barrier function with higher potency than WPI and WPI-GOS. These results strongly suggest that cheese whey components may be used by the functional foods industry as ingredients to improve intestinal health with emphasis on GMP as anti-inflammatory ingredient.
